Impact of Tofacitinib on Fracture Risk in Rheumatoid Arthritis

被引：0
|
作者：
Hansen, Karen E. [1 ]
Mortezavi, Mahta [2 ]
Nagy, Edward [3 ]
Wang, Cunshan [4 ]
Connell, Carol A. [4 ]
Radi, Zaher [5 ]
Litman, Heather J. [6 ]
Adami, Giovanni [7 ]
Rossini, Maurizio [7 ]
机构：
[1] Univ Wisconsin, Rheumatol Div, Dept Med, Sch Med & Publ Hlth, Madison, WI USA
[2] Pfizer Inc, New York, NY USA
[3] Pfizer Ltd, Tadworth, England
[4] Pfizer Inc, Groton, CT USA
[5] Pfizer Inc, Cambridge, MA USA
[6] CorEvitas LLC, Waltham, MA USA
[7] Univ Verona, Dept Med, Rheumatol Unit, Verona, Italy
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1431
引用
收藏
页码：2821 / 2824
页数：4
相关论文
共 50 条
  • [1] Fracture in clinical studies of tofacitinib in rheumatoid arthritis
    Hansen, Karen E.
    Mortezavi, Mahta
    Nagy, Edward
    Wang, Cunshan
    Connell, Carol A.
    Radi, Zaher
    Litman, Heather J.
    Adami, Giovanni
    Rossini, Maurizio
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
  • [2] IMPACT OF JAKI, TOFACITINIB, ON CV RISK IN RHEUMATOID ARTHRITIS: JAKI CV RISK IMPACT STUDY
    Syngle, A.
    Verma, I.
    Garg, N.
    Chauhan, K.
    Patyal, S.
    Syngle, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 716 - 717
  • [3] Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
    Ytterberg, Steven R.
    Bhatt, Deepak L.
    Mikuls, Ted R.
    Koch, Gary G.
    Fleischmann, Roy
    Rivas, Jose L.
    Germino, Rebecca
    Menon, Sujatha
    Sun, Yanhui
    Wang, Cunshan
    Shapiro, Andrea B.
    Kanik, Keith S.
    Connell, Carol A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04): : 316 - 326
  • [4] Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
    Ozdede, Ayse
    Yazici, Hasan
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (18): : 1766 - 1766
  • [5] Cardioprotective Impact of JAKi, Tofacitinib, on CV Risk in Rheumatoid Arthritis: JAKi CV Risk Impact Study
    Syngle, Ashit
    Verma, Inderjeet
    Garg, Nidhi
    Chauhan, Kanchan
    Patyal, Sapna
    Syngle, Devaansh
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 868 - 869
  • [6] Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis REPLY
    Ytterberg, Steven R.
    Bhatt, Deepak L.
    Connell, Carol A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (18): : 1768 - 1768
  • [7] Analysis of the Impact of Tofacitinib Treatment on Weight in Patients with Rheumatoid Arthritis
    Wollenhaupt, Juergen
    Morel, Jacques
    Daien, Claire
    Ruyssen-Witrand, Adeline
    Lukas, Cedric
    Richez, Christophe
    Shapiro, Andrea
    Chapman, Douglass S.
    Cros, Magali
    Rivas, Jose L.
    Citera, Gustavo
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [8] ANALYSIS OF THE IMPACT OF TOFACITINIB TREATMENT ON WEIGHT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Wollenhaupt, J.
    Morel, J.
    Daien, C.
    Ruyssen-Witrand, A.
    Lukas, C.
    Richez, C.
    Shapiro, A.
    Chapman, D.
    Cros, M.
    Rivas, J. L.
    Citera, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1148 - 1149
  • [9] Tofacitinib for rheumatoid arthritis Reply
    Burmester, Gerd R.
    Benda, Birgitta
    Gruben, David
    Bradley, John
    Mebus, Charles
    LANCET, 2013, 381 (9880): : 1812 - 1813
  • [10] Tofacitinib: A Review in Rheumatoid Arthritis
    Sohita Dhillon
    Drugs, 2017, 77 : 1987 - 2001
12345